SANUWAVE Health Stock Price, News & Analysis (OTCMKTS:SNWV)

$0.20 0.01 (5.26 %)
(As of 01/23/2018 10:59 AM ET)
Previous Close$0.18
Today's Range$0.18 - $0.20
52-Week Range$0.08 - $0.28
Volume17,700 shs
Average Volume761,121 shs
Market Capitalization$27.85 million
P/E Ratio-5.00
Dividend YieldN/A
Beta-0.19

About SANUWAVE Health (OTCMKTS:SNWV)

SANUWAVE Health, Inc. is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, enabling to restore the body's normal healing processes and regeneration. It is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions.

Receive SNWV News and Ratings via Email

Sign-up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:SNWV
CUSIPN/A
Phone770-419-7525

Debt

Debt-to-Equity Ratio-0.57%
Current Ratio0.11%
Quick Ratio0.07%

Price-To-Earnings

Trailing P/E Ratio-5
Forward P/E Ratio-6.67
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.38 million
Price / Sales20.18
Cash FlowN/A
Price / CashN/A
Book Value($0.05) per share
Price / Book-4.00

Profitability

Trailing EPS($0.04)
Net Income$-6,430,000.00
Net Margins-486.83%
Return on EquityN/A
Return on Assets-666.33%

Miscellaneous

Employees6
Outstanding Shares139,250,000

SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions

What is SANUWAVE Health's stock symbol?

SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its earnings results on Monday, November, 20th. The company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The firm earned $0.16 million during the quarter, compared to analysts' expectations of $0.48 million. View SANUWAVE Health's Earnings History.

When will SANUWAVE Health make its next earnings announcement?

SANUWAVE Health is scheduled to release their next quarterly earnings announcement on Tuesday, April, 3rd 2018. View Earnings Estimates for SANUWAVE Health.

Who are some of SANUWAVE Health's key competitors?

Who are SANUWAVE Health's key executives?

SANUWAVE Health's management team includes the folowing people:

  • Kevin A. Richardson II, Chairman of the Board, Co-Chief Executive Officer (Age 46)
  • Lisa E. Sundstrom, Chief Financial Officer (Age 45)
  • Maj-Britt Kaltoft, Director
  • John Fritzen Nemelka, Director (Age 49)
  • A. Michael Stolarski, Director
  • Alan L. Rubino, Independent Director (Age 60)

How do I buy SANUWAVE Health stock?

Shares of SANUWAVE Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SANUWAVE Health's stock price today?

One share of SANUWAVE Health stock can currently be purchased for approximately $0.20.

How big of a company is SANUWAVE Health?

SANUWAVE Health has a market capitalization of $27.85 million and generates $1.38 million in revenue each year. The company earns $-6,430,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. SANUWAVE Health employs 6 workers across the globe.

How can I contact SANUWAVE Health?

SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]


MarketBeat Community Rating for SANUWAVE Health (SNWV)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about SANUWAVE Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

SANUWAVE Health (OTCMKTS:SNWV) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

SANUWAVE Health (OTCMKTS:SNWV) Earnings History and Estimates Chart

Earnings by Quarter for SANUWAVE Health (OTCMKTS:SNWV)

SANUWAVE Health (OTCMKTS SNWV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/3/2018        
11/20/2017Q3 2017($0.01)($0.01)$0.48 million$0.16 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.01)($0.01)$0.24 million$0.11 millionViewN/AView Earnings Details
4/4/2017Q4 2016($0.01)($0.02)ViewN/AView Earnings Details
11/8/2016Q3 2016($0.01)($0.01)ViewN/AView Earnings Details
8/15/2016Q2 2016($0.01)($0.01)ViewN/AView Earnings Details
5/17/2016Q1 2016($0.02)($0.02)ViewN/AView Earnings Details
3/30/2016Q4 2015($0.02)($0.02)ViewN/AView Earnings Details
11/12/2015Q3 2015($0.02)($0.02)ViewN/AView Earnings Details
8/11/2015Q2 2015($0.02)($0.02)ViewN/AView Earnings Details
5/6/2015Q1 2015($0.02)($0.02)ViewN/AView Earnings Details
11/12/2014Q3 2014($0.04)($0.03)ViewN/AView Earnings Details
8/6/2014($0.04)($0.03)$0.20 million$0.24 millionViewN/AView Earnings Details
5/13/2014Q1 2014($0.05)($0.06)ViewN/AView Earnings Details
11/12/2013Q3($0.14)ViewN/AView Earnings Details
11/12/2013($0.08)($0.06)ViewN/AView Earnings Details
8/14/2013Q2 2013($0.10)($0.09)ViewN/AView Earnings Details
5/14/2013Q1 2013($0.07)($0.07)ViewN/AView Earnings Details
3/26/2013Q4 2012($0.10)($0.07)ViewN/AView Earnings Details
11/14/2012Q3 2012($0.05)($0.07)ViewN/AView Earnings Details
8/8/2012Q2 2012($0.08)($0.07)ViewN/AView Earnings Details
5/14/2012Q1 2012($0.10)($0.09)ViewN/AView Earnings Details
3/14/2012Q4 2011($0.12)($0.11)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.13)($0.10)ViewN/AView Earnings Details
8/10/2011Q2 2011($0.20)($0.13)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.18)($0.14)ViewN/AView Earnings Details
3/28/2011Q4 2010($0.34)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

SANUWAVE Health (OTCMKTS:SNWV) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS

Dividends

Dividend History for SANUWAVE Health (OTCMKTS:SNWV)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

SANUWAVE Health (OTCMKTS SNWV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.40%
Institutional Ownership Percentage: 0.47%
Insider Trades by Quarter for SANUWAVE Health (OTCMKTS:SNWV)

SANUWAVE Health (OTCMKTS SNWV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/28/2016Anthony Michael StolarskiDirectorBuy500,000$0.06$30,000.003,724,626View SEC Filing  
3/17/2014Joseph ChiarelliCEOBuy80,000$0.50$40,000.00View SEC Filing  
3/17/2014Kevin A Richardson IIDirectorBuy100,000$0.50$50,000.00View SEC Filing  
10/9/2013Joseph ChiarelliCEOBuy41,667$0.60$25,000.20View SEC Filing  
10/9/2013Kevin A Richardson IIDirectorBuy35,312$0.60$21,187.20View SEC Filing  
9/19/2013Barry J JenkinsCFOBuy13,500$0.74$9,990.00View SEC Filing  
8/13/2013Christopher M CashmanMajor ShareholderSell33,500$0.77$25,795.00View SEC Filing  
6/11/2013Christopher M CashmanMajor ShareholderSell34,800$0.80$27,840.00View SEC Filing  
6/6/2013Christopher M CashmanMajor ShareholderSell46,100$0.89$41,029.00View SEC Filing  
5/29/2013Christopher M CashmanMajor ShareholderSell2,827$0.84$2,374.68View SEC Filing  
5/22/2013Christopher M CashmanMajor ShareholderSell73,461$0.96$70,522.56View SEC Filing  
5/17/2013Christopher M CashmanMajor ShareholderSell26,539$1.00$26,539.00View SEC Filing  
11/27/2012David Nephi Jr. NemelkaMajor ShareholderBuy4,000,000$0.25$1,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

SANUWAVE Health (OTCMKTS SNWV) News Headlines

Source:
DateHeadline
SANUWAVE Announces Exhibition at SAWC Commercialization of dermaPACE Has Begun Visit us at Booth Number 108SANUWAVE Announces Exhibition at SAWC Commercialization of dermaPACE Has Begun Visit us at Booth Number 108
finance.yahoo.com - January 19 at 12:21 PM
Uptick Newswire “Stock Day” Interviews CEO of SANUWAVE Health on the 2018 Expansion and the Newly U.S. Marketed dermaPACE SystemUptick Newswire “Stock Day” Interviews CEO of SANUWAVE Health on the 2018 Expansion and the Newly U.S. Marketed dermaPACE System
finance.yahoo.com - January 10 at 10:50 AM
Still Lots Of Unknowns But U.S. FDA Clearance Is Major Win For SNWVStill Lots Of Unknowns But U.S. FDA Clearance Is Major Win For SNWV
finance.yahoo.com - January 8 at 10:57 AM
Sanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.Sanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.
finance.yahoo.com - January 2 at 10:34 AM
ValuEngine Lowers SANUWAVE Health (SNWV) to Strong SellValuEngine Lowers SANUWAVE Health (SNWV) to Strong Sell
www.americanbankingnews.com - January 1 at 9:58 AM
SANUWAVE Health to Hold Call to Discuss FDA Approval Letter on Tuesday, January 2, 2018SANUWAVE Health to Hold Call to Discuss FDA Approval Letter on Tuesday, January 2, 2018
feeds.benzinga.com - December 29 at 9:49 AM
FY2017 Earnings Forecast for Sanuwave Health Inc. (SNWV) Issued By Zacks Investment ResearchFY2017 Earnings Forecast for Sanuwave Health Inc. (SNWV) Issued By Zacks Investment Research
www.americanbankingnews.com - December 1 at 3:01 PM
SNWV: Disappointing Q3 Revenue But SNWV Expects Record Sales in 2018SNWV: Disappointing Q3 Revenue But SNWV Expects Record Sales in 2018
finance.yahoo.com - November 29 at 3:44 PM
SANUWAVE Healths (SNWV) CEO Kevin Richardson on Q3 2017 Results - Earnings Call TranscriptSANUWAVE Health's (SNWV) CEO Kevin Richardson on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 22 at 8:17 AM
Sanuwave Health Inc. (SNWV) Announces  Earnings ResultsSanuwave Health Inc. (SNWV) Announces Earnings Results
www.americanbankingnews.com - November 21 at 5:55 PM
SANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound CareSANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care
finance.yahoo.com - November 16 at 6:31 PM
Sanuwave Health Inc. (SNWV) Scheduled to Post Earnings on TuesdaySanuwave Health Inc. (SNWV) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - November 14 at 9:10 AM
SANUWAVE Health to Hold Third Quarter 2017 Financial Results and Business Update Call on Tuesday, November 21, 2017SANUWAVE Health to Hold Third Quarter 2017 Financial Results and Business Update Call on Tuesday, November 21, 2017
finance.yahoo.com - November 14 at 8:03 AM

SEC Filings

SANUWAVE Health (OTCMKTS:SNWV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

SANUWAVE Health (OTCMKTS SNWV) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.